Health-related quality of life in men with prostate cancer

Prostate Cancer and Prostatic Diseases

Volumn 1, Issue 5, 1998, Pages 228-235

  Litwin, M S ^a   Penson, D F ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Outcomes; Prostate cancer; Quality of life

Indexed keywords

EID: 3142613841     PISSN: 13657852     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.pcan.4500249     Document Type: Article

References (120)

1. Crawford ED et al. Comparison of perspectives on prostate cancer: analyses of survey data. Urology 1997; 50: 366-372.
2. Patrick DL, Erickson P. Assessing health-related quality of life for clinical decision-making. In: Walker SR, Rosser RM (eds). Quality of Life Assessment: Key issues in the 1990s. Dordrecht, Kluwer Academic Publishers: Dordrecht, 1993, pp 291-313.
3. Osoba D. Measuring the effect of cancer on quality of life. In: Osoba D (ed). Effect of Cancer on Quality of Life. CRC Press: Boca Raton, 1991, pp 405-437.
4. World Health Organization. Constitution of the World Health Organization, Basic Documents. World Health Organization: Geneva, 1948.
5. Leplege A, Hunt S. The problem of quality of life in medicine. JAMA 1997; 278: 47-50.
6. Altwein J et al. How is quality of life in prostate cancer patients influenced by modern treatment? The Wallenberg Symposium. Urology 1997; 49 (Suppl 4A): 66-76.
7. Fayers PM, Jones DR. Measuring and anlayzing quality of life in cancer clinical trials: a review. Stat Med 1983; 2: 429-446.
8. Aaronson NK, da Silva FC. Prospects for the future: quality of life evaluation in prostatic cancer protocols. Prog Clin Biol Res 1987; 243B: 501-512.
9. Penson DF et al. Transition in health-related quality of life during the first nine months after diagnosis with prostate cancer. Prost Ca Prost Dis 1998; 1: 134-143.
10. Herr HW. Quality of life in prostate cancer patients. CA Cancer Clin J 1997; 47: 207-217.
11. Talcott JA. Quality of life in early prostate cancer. Do we know enough to treat? Hematol Oncol Clin North Am 1996; 10: 691-701.
12. Foss SD. Quality of life in prostate cancer: what are the issues and how are they measured? Eur Urol 1996; 29 (Suppl 2): 121-123.
13. Balducci L. Perspectives on quality of life of older patients with cancer. Drugs Aging 1994; 4: 313-324.
14. Jakobsson L, Hallberg IR, Loven L. Experiences of daily life and life quality in men with prostate cancer. An explorative study. Part I. Eur J Cancer Care (English Language Edition) 1997; 6: 108-116.
15. Krongrad A et al. Predictors of general quality of life in patients with benign prostate hyperplasia or prostate cancer. J Urol 1997; 157: 534-538.
16. Fossa S et al. Quality of life in prostate cancer patients. Prostate 1992; 4 (Suppl): 145-148.
17. Litwin MS. Measuring health related quality of life in men with prostate cancer. J Urol 1994; 152: 1882-1887.
18. da Silva FC, Reis E, Costa T, Denis L. Quality of Life Committee of the EORTC Genitourinary Group. Quality of life in patients with prostatic cancer: A feasibility study. Cancer Suppl 1993; 71: 1138-1142.
19. Tulsky DA. An introduction to test theory. Oncology 1990; 4: 43-48.
20. Olschewski M, Schumacher M. Statistical anlaysis of quality of life data in cancer clinical trials. Stat Med 1990; 9: 749-763.
21. Messick S. The once and future issues of validity: assessing the meaning and consequences of measurement. In: Wainer H, Braun HI (eds). Test Validity. Lawrence Erlbaum Associates: Hillside, NJ, 1988.
22. Tchekmedyian NS, Cella DF. Quality of Life in Current Oncology Practice and Research. Dominus Publishing: Williston Park, NY, 1991.
23. Tannock IF. Management of breast and prostate cancer: how does quality of life enter the equation? Oncology 1990; 4: 149-156.
24. Patrick DL, Deyo RA. Generic and disease-specific measures in assessing health care status and quality of life. Med Care 1989; 27 (Suppl): S217-S232.
25. Parkerson GR, Jr et al. Disease-specific versus generic measurement of health-related quality of life in insulin-dependent diabetic patients. Med Care 1993; 31: 629-639.
26. Tarlov AR et al. The Medical Outcomes Study. An application of methods for monitoring the results of medical care. JAMA 1989; 262: 925-930.
27. Ware JE, Sherbourne CD, Davies AR. Developing and testing the MOS 20-item short-form health survey: a general population application. In: Stewart AL, Ware JE, (eds). Measuring Functionaing and Well-Being: The Medical Outcomes Study Approach. Duke University Press: Durham, NC, 1992.
28. Stewart AL, Hays RD, Ware JE. The MOS short-form general health survey: Reliability and validity in a patient population. Med Care 1988; 26: 724-735.
29. Ware JE, Jr., Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992; 30: 473-483.
30. McHorney CA et al. The validity and relative precision of MOS short- and long-form health status scales and Dartmouth COOP charts. Results from the Medical Outcomes Study. Med Care 1992; 30 (Suppl): MS253-MS265.
31. Stewart AL et al. Functional status and well-being of patients with chronic conditions. Results from the Medical Outcomes Study. JAMA 1989; 262: 907-913.
32. Ware JE. SF-36 Health Survey. Manual and Interpretation Guide. 2nd edn. The Health Institute: Boston, MA, 1997.
33. McDowell I, Ewell C. Measuring Health: A Guide to Rating Scales and Questionnaires. Oxford University Press: New York, 1987.
34. Kaplan RM, Bush JW, Berry CC. Health status: types of validity and the index of well-being. Health Serv Res 1976; 11: 478-507.
35. Kaplan RM, Bush JW. Health-related quality of life measurement for evaluation research and policy analysis. Health Psychol 1982; 1: 61.
36. Kaplan RM, Anderson JP. A general health policy model: update and applications. Health Serv Res 1988; 23: 203-235.
37. Hays RM, Shapiro MF. An overview of generic health-related quality of life measures for HIV research. Qual Life Res 1992; 1: 91-97.
38. Deyo RA, Inui TS, Leininger JD, Overman SS. Measuring functional outcomes in chronic disease: a comparison of traditional scales and a self-administered health status questionnaire in patients with rheumatoid arthritis. Med Care 1983; 21: 180-192.
39. Bergner M et al. The sickness impact profile: validation of a health status measure. Med Care 1976; 14: 57-67.
40. Bergner M, Bobbitt RA, Carter WB, Gilson BS. The sickness impact profile: development and final revision of a health status measure. Med Care 1981; 19: 787-805.
41. Moinpur CM et al. Quality of life end points in cancer clinical trials: review and recommendations. J Natl Cancer Inst 1989; 81: 485-495.
42. Hunt SM, McEwen J, McKenna SP. Measuring health status: a new tool for clinicians and epidemiologists. J Roy Coll Gen Pract 1985; 35: 185-188.
43. McDowell IW, Martini CJM, Waugh W. A method for self-assessment of disability before and after hip replacement operatioins. Br Med J 1978; 2: 857-859.
44. Martini CJ, McDowell I. Health status: patient and physician judgements. Health Serv Res 1976; 11: 508-515.
45. Gill TM, Feinstein AR. A critical appraisal of the quality-of-life measurements. JAMA 1994; 272: 619-626.
46. Ganz PA, Schag CAC, Lee JJ, Sim MS. The CARES: a generic measure of health related quality of life for patients with cancer. Qual Life Res 1992; 1: 19-29.
47. Schag CAC, Heinrich RL. Development of a comprehensive quality of life measurement tool: CARES. Oncology 1990; 4: 135-138.
48. Schag CAC, Heinrich RL. Cancer Rehabilitation Evaluation System (CARES) Manual. CARES Consultants: Los Angeles, 1988.
49. Schag CA et al. Quality of life in adult survivors of lung, colon and prostate cancer. Qual Life Res 1994; 3: 127-141.
50. Schag CAC, Heinrich RL, Ganz PA. The Cancer Rehabilitation Evaluation System (CARES): the short form (CARES-SF). Proc Am Soc Clin Oncol 1989; 8: 316.
51. Schipper H, Clinch J, McMurray A, Levitt M. Measuring quality of life in cancer patients: the functional living index-cancer: development and validation. J Clin Oncol 1984; 2: 472-483.
52. Finkelstein DM et al. A pilot study of the functional living index-cancer (FLIC) scale for the assessment of quality of life for metastatic lung cancer patients. Am J Clin Oncol 1988; 11: 630-633.
53. Aaronson NK et al. The European Organization for Research and the treatment of Cancer QLQ-C30: a quality of life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993; 85: 365-376.
54. Borghede G, Sullivan M. Measurement of quality of life in localized prostastic cancer patients treated with radiotherapy. Development of a prostate cancer-specific module supplementing the EORTC QLQ-C30. Qual Life Res 1996; 5: 212-222.
55. Borghede G, Karlsson J, Sullivan M. Quality of life in patients with prostatic cancer: Results from a Swedish population study. J Urol 1997; 158: 1477-1485.
56. Albertsen PC et al. Health-related quality of life among patients with metastatic prostate cancer. Urology 1997; 49: 207-216.
57. Cella DF, Tulsky DS. Measuring quality of life today. Oncology 1990; 4: 29-38.
58. Tulsky DS et al. Development and validation of new quality of life measures for patients with cancer. Proc Soc Behav Med 1990; 11: 45.
59. Cella DF, Cherin A. Quality of life during and after cancer treatment. Compr Ther 1988; 14: 69-75.
60. Cella DF et al. Relationship of psychological distress, extent of disease, and performance status in patients with lung cancer. Cancer 1987; 60: 1661-1667.
61. Esper P et al. Measuring quality of life in men with prostate cancer using the Functional Assessment of Cancer Therapy - Prostate instrument. Urology 1997; 50: 920-928.
62. Litwin MS et al. The UCLA Prostate Cancer Index: Development, reliability, and validity of a health-related quality of life measure. Med Care 1998; In press.
63. Lubeck D, Litwin M, Henning J, Carroll P. Measurement of health-related quality of life in men with prostate cancer: Data from the CaPSURE database. Qual Life Res 1997; 6: 385-392.
64. Krongrad A et al. Reliability of Spanish Translations of Select Urological Quality of Life Instruments. J Urol 1997; 158: 493-496.
65. Shrader-Bogen CL, Kjellberg JL, McPherson CP, Murray CL. Quality of life and treatment outcomes: prostate carcinoma patients' perspectives after prostatectomy or radiation therapy. Cancer 1997; 79: 1977-1986.
66. O'Leary MP et al. A brief sexual function inventory for urology. Urology 1995; 46: 697-706.
67. Waterhouse J, Metcalfe MC. Development of the sexual adjustment questionnaire. Oncol Nurs Forum 1986; 13: 53-59.
68. Villavicencio H. Quality of life of patients with advanced and metastatic prostatic carcinoma. Eur Urol 1993; 24 (Suppl 2): 118-121.
69. Fossa SD. Quality of life in advanced prostate cancer. Sem Oncol 1996; 6 (Suppl 14): 32-34.
70. Fossa SD. Quality of life after palliative radiotherapy in patients with hormone-resistant prostate cancer: single institution experience. Br J Urol 1994; 74: 345-351.
71. Ganz PA, Schag CAC, Lee JJ, Sim MS. The CARES: a generic measure of health related quality of life for patients with cancer. Qual Life Res 1992; 1: 19-29.
72. Kornblith AB et al. Quality of life of patients with prostate cancer and their spouses: the values of a database in clinical care. Cancer 1994; 73: 2791-2802.
73. van Andel G, Kurth KH, de Haes JC. Quality of life in patients with prostatic carcinoma: a review and results of a study in N+ disease. Prostate-specific antigen as predictor of quality of life. Urol Res 1997; 25 (Suppl 2): S79-S88.
74. Lucas MD, Strijdom SC, Berk M, Hart GA. Quality of life, sexual functioning and sex role identity after surgical orchidectomy in patients with prostatic cancer. Scand J Urol Nephrol 1995; 29: 497-500.
75. Litwin MS, Shpall AI, Dorey F, Nguyen T-H. Quality of life outcomes in long term survivors of advanced prostate cancer. Am J Clin Oncol 1998; In press.
76. a Silva FC et al. The quality of life of patients with newly diagnosed M1 prostate cancer: experience wiht EORTC clinical trial 30853. Eur J Cancer 1996; 32A: 72-77.
77. da Silva FC. Quality of life in prostatic carcinoma. Eur Urol 1993; 24 (Suppl 2): 113-117.
78. Clark JA et al. Dimensions of quality of life expressed by men treated for metastatic prostate cancer [abstract]. Alisr Fhsr Annu Meet Abstr Book 1995; 12: 141-142,
79. Cassileth BR et al. Patients' choice of treatment in stage D prostate cancer. Urology 1989; 33 (Suppl): 57-62.
80. Cassileh BR et al. Quality of life and psychosocial status in stage D prostate cancer. Qual Life Res 1992; 1: 323-329.
81. Herr HW, Kornblith AB, Ofman U. A comparison of the quality of life of patients with metastatic prostate cancer who received or did not receive hormonal therapy. Cancer 1993; 71 (Suppl 3): 1143-1150.
82. Tannock IF et al. Treatment of metastatic prostate cancer with low-dose prednisone: evaluation of pain and quality of life as pragmatic indices of response. J Clin Oncol 1989; 7: 1-7.
83. Melzack R. The McGill Pain Questionnaire: major properties and scoring methods. Pain 1975; 1: 277-299.
84. Cleary PD, Morrissey G, Oster G. Health-related quality of life in patients with advanced prostate cancer: a multinational perspective. Qual Life Res 1995; 4: 207-220.
85. Fossa SD et al. Quality of life and treatment of hormone resistant metastatic prostatic cancer. Eur J Cancer 1990; 11: 1133-1136.
86. Litwin MS, Lubeck DP, Henning JM, Carroll PR. Differences in urologist and patient assessments of health-related quality of life in men with prostate cancer: results from the CaPSURE™ database. J Urol, 159: 1988-1992.
87. Watkins-Bruner D et al. RTOG's first quality of life study - RTOG 90-20: a phase trial of external beam radiation with etanidazole for locally advanced prostate cancer. Int J Rad Oncol Biol Phys 1995; 33: 901-906.
88. Lucas MD, Strijdom SC, Berk M, Hart GA. Quality of life, sexual functioning and sex role identity after surgical orchidectomy in patients with prostatic cancer. Scand J Urol Nephrol 1995; 4: 497-500.
89. Simpson KM, Revicki D, Mohler JL. Quality of life with clinically-localized prostatic carcinoma: prostatectomy versus "watchful waiting. Annual Meet Int Soc Technol Assess Health Care 1995; 11: 19A.
90. Mazur DJ, Merez JF. Older patients' willingness to trade off urologic adverse outcomes for a better chance at five-year survival in the clincal setting of prostate cancer. J Am Geriatr Soc 1995; 43: 979-984.
91. Volk RJ et al. Preferences of husbands and weives for prostate cancer screening. Arch Fam Med 1997; 6: 72-76.
92. Bennett CL et al. A comparison of perspectives on prostate cancer: analysis of utility assessments of patients and physicians. Eur Urol 1977; 32 (Suppl 3): 86-88.
93. Litwin MS et al. Quality-of-life outcomes in men treated for localized prostate cancer. JAMA 1995; 273: 129-135.
94. Lim AJ et al. Quality of Life: Radical Prostatectomy versus Radiation Therapy for Prostate Cancer. J Urol 1995; 154: 1420-1425.
95. Jacobson AF et al. The measurement of psychological states by use of factors derived from a combination of items from mood and symptom checklist. J Clin Psychol 1978; 34: 677-685.
96. Gburek B, Harmon B, Chodak GW. Quality of life assessment in patients with prostate cancer treated by radical prostatectomy, radiation therapy, or a combination. J Urol 1992; 147: 466A.
97. Litwin MS et al. Quality of life in men with prostate cancer: a pilot study. J Urol 1993; 149: 494A.
98. Fowler FJ et al. Patient-reported complications and followup treatment after radical prostatectomy. Urology 1993; 42: 622-629.
99. Fowleer FJ et al. Effect of radical prostatectomy for prostate cancer on patient quality of life: results from a Medicare survey. Urology 1995; 45: 1007-1015.
100. Chodak G et al. Patient-reported outcomes following radical prostatectomy performed at eight academic institutions. J Urol 1995; ; 153: 390A.
101. Talcott JA et al. Patient-reported impotence and incontinence after nerve-sparing radical prostatectomy. J Nat Cancer Inst 1997; 89: 1117-1123.
102. Rieker P et al. Health-related quality of life following treatment for early stage prostate cancer. Proc Am Soc Clin Oncol 1993; 12: 452A.
103. Perez MA et al. Quality of life and sexuality following radical prostatecomy in patients with prostate cancer who use or do not use erectile aids. Urology 1997; 50: 740-746.
104. Pedersen KV et al. Quality of life after radical retropubic prostatecomy for carcinoma of the prostate. Eur Urol 1993; 24: 7-11.
105. Klein CE, Prochazka A, Spitzer AL. Spousal report of quality of life in treatment for localized prostate cancer. Proc Am Soc Clin Oncol 1996; 15: 508A.
106. Braslis KG, Santa-Cruz C, Brickman AL, Soloway MS. Quality of life 12 months after radical prostatectomy. Br J Urol 1995; 75: 48-53.
107. Rossetti SR, Terrone C. Quality of life in prostate cancer patients. Eur Urol 1996; 30 (Suppl 1): 44-48.
108. Herr HW. Quality of life of incontinent men after prostatectomy. J Urol 1994; 151: 652-654.
109. Fossa SD et al. Influence of urological morbidity on quality of life in patients with prostate cancer. Eur Urol 1997; 31 (Suppl 3): 3-8.
110. Jonler M et al. A prospective study of quantification of urinary incontinence and quality of life in patients undergoing radical retropubic prostatectomy. Urology 1996; 48: 433-440.
111. Beard CJ et al. Complications after treatment with externalbeam irradiation in early-stage prostate cancer patients: a prospective multiinstitutional outcomes study. J Clin Oncol 1997; 15: 223-229.
112. Caffo O, Fellin G, Graffer U, Luciani L. Assessment of quality of life after radical radiotherapy for prostate cancer. Br J Urol 1996; 78: 557-563.
113. Fowler FJ Jr et al. Outcomes of external-beam radiation therapy for prostate cancer: a study of Medicare beneficiaries in three surveillance, epidemiology, and end results areas. J Clin Oncol 1996; 14: 2258-2265.
114. Fransson P, Widmark A. Self-assessed sexual function after pelvic irradiation for prostate carcinoma. Comparison with an age-matched control group. Cancer 1996; 78: 1066-1078.
115. Helgason AR et al. Decreases sexual capacity after external radiation therapy for prostate cancer impairs quality of life. Int J Radiat Oncol Biol Phys 1995; 32: 33-39.
116. Roach M, 3rd, Chinn DM, Holland J, Clarke M. A pilot survey of sexual function and quality of life following 3D conformal radiotherapy for clinically localized prostate cancer. Int J Radiat Oncol Biol Phys 1996; 35: 869-874.
117. Widmark A, Fransson P, Tavelin B. Self-assessment questionnaire for evaluating urinary and intestinal late side effects after pelvic radiotherapy in patients with prostate cancer compared with an age-matched control population. Cancer 1994; 74: 2520-2532.
118. Fleshner N, Herschorn S. The artificial urinary sphincter for post-radical prostatectomy incontinence: impact on urinary symptoms and quality of life. J Urol 1996; 155: 1260-1264.
119. Haab F, Trockman BA, Zimmern PE, Leach GE. Quality of life and continence assessment of the artificial urinary sphincter in men with minimum 3.5 years of follow-up. J Urol 1997; 158: 435-439.
120. Sharp JW. Expanding the definition of quality of life for prostate cancer. Cancer Suppl 1993; 71: 1078-1082.